HelixNano Companies
HelixNano is a biotech startup that utilizes artificial intelligence to develop vaccines for genetic diseases. With a focus on cancer and COVID-19, the organization has successfully created cancer vaccines and is now working on COVID-19 vaccine candidates. HelixNano aims to create a vaccine that not only protects against the current virus but also future coronaviruses. As a Y Combinator and venture-backed company, HelixNano is dedicated to using synthetic biology to revolutionize the field of genetic disease treatment.
Investors
Technology:
Companies
Industry:
AI R&D Pharma (DPI)
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2013
Employees Number:
18
Register and Claim Ownership